Target Audience: This activity is designed for physicians, nurses, PAs, pharmacists, social workers, peer recovery support specialists, psychologists, other behavioral health providers. This activity is accredited for physicians, nurses, PAs, pharmacists, social workers, interprofessional teams and other health professionals.

Webinar Description: Research indicates a lack of training and programming specific to treating and managing co-occurring opioid and stimulant use disorders, despite the increased risk of overdose bolstered by the ever-changing and adulterated drug supply. While MOUD is the gold standard of care for treating OUD, there are no FDA-approved medications for treating stimulant use disorder, though behavioral therapies like contingency management have been well-studied. These challenges highlight the need to identify promising treatment strategies to ensure individuals with co-occurring opioid and stimulant use disorders are effectively engaged in care to prevent overdose. This session will equip BH providers and organizations in this space, including Community Behavioral Health Clinics (CCBHCs), with the tools necessary to effectively engage and provide quality, team-based care and services to individuals with co-occurring opioid and stimulant use disorders in order to improve health outcomes, reduce overdose risk, and support long-term recovery.

Educational Objectives:

• Describe the broad context of co-occurring opioid and stimulant use and overdose risk in the U.S.
• Review evidence-based strategies for treating opioid use disorders and promising practices for stimulant use
• Identify evidence-based and promising strategies for treating co-occurring opioid and stimulant use disorders
• Review psychiatric co-morbidities associated with opioid and stimulant use disorders

Continuing Education information:

In support of improving patient care, this activity has been planned and implemented by American Academy of Addiction Psychiatry (AAAP) and National Council for Mental Wellbeing (NCMW). AAAP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Designation Statement

American Academy of Addiction Psychiatry designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Designation Statement

American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1 Nursing Contact Hours.

PA Designation Statement

American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Social Work Designation Statement

As a Jointly Accredited Organization, American Academy of Addiction Psychiatry (AAAP) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AAAP maintains responsibility for this course. Social workers completing this course receive 1 continuing education credit.

Interprofessional Continuing Education (IPCE) Designation Statement

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education credits for learning and change.

Pharmacy Designation Statement

This course has been approved for 1 hour of pharmacy continuing education credit. The approval number issued is Universal Activity Number: UAN JA4008192-9999-23-037-L01-P

Other Health Professionals

Participants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credits™.